Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
An autosomal recessive disorder caused by mutations in the HGF gene, encoding hepatocyte growth factor receptor. It is characterized by profound deafness.
Features include: Prelingual sensorineural hearing impairment.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Ears | 1 | Prelingual sensorineural hearing impairment |
HGF encodes hepatocyte growth factor (728 aa). Potent mitogen for mature parenchymal hepatocyte cells, seems to be a hepatotrophic factor, and acts as a growth factor for a broad spectrum of tissues and cell types. Highest expression in Lung (16.1 TPM) and Artery Coronary (10.4 TPM).
Autosomal recessive nonsyndromic hearing loss 39 is associated with mutations in the HGF gene on chromosome 7.
HGF is classified as a druggable target (Clinically Actionable, Druggable Genome, Enzyme, Growth Factor, Kinase, and Protease categories) with score 10.0.
Genetic testing for HGF is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for autosomal recessive nonsyndromic hearing loss 39 has been reported in the published literature.
No clinical trials have been registered for autosomal recessive nonsyndromic hearing loss 39.
8 publications have been identified in PubMed for autosomal recessive nonsyndromic hearing loss 39. Research spans Case Report / Case Series (38%), Epidemiology / Natural History (25%), and Diagnostic / Biomarker (13%).
Gan H (2026). [PMID: 41578500](https://pubmed.ncbi.nlm.nih.gov/41578500/). *Medicine (Baltimore)*. [Case Report / Case Series]
Meisel M (2025). [PMID: 40491524](https://pubmed.ncbi.nlm.nih.gov/40491524/). *Am J Ophthalmol Case Rep*. [Case Report / Case Series]
Vincent A (2025). [PMID: 40324556](https://pubmed.ncbi.nlm.nih.gov/40324556/). *Am J Ophthalmol*. [Epidemiology / Natural History]
Damrongchietanon T (2025). [PMID: 40998904](https://pubmed.ncbi.nlm.nih.gov/40998904/). *Sci Rep*. [Diagnostic / Biomarker]
Yan D (2025). [PMID: 39182490](https://pubmed.ncbi.nlm.nih.gov/39182490/). *Audiol Neurootol*. [Epidemiology / Natural History]
Data assembled from 5 of 12 sources · Last updated Sep 20, 2026, 6:03 PM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
Liu Y (2025). [PMID: 40555484](https://pubmed.ncbi.nlm.nih.gov/40555484/). *Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi*. [Case Report / Case Series]
Zhao H (2025). [PMID: 40744884](https://pubmed.ncbi.nlm.nih.gov/40744884/). *Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi*. [Basic Science / Preclinical]
Jurca AD (2024). [PMID: 39064493](https://pubmed.ncbi.nlm.nih.gov/39064493/). *Medicina (Kaunas)*. [Review / Meta-Analysis]